Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide

Published 2008 View Full Article

Authors

Keywords

Journal

BLOOD

Volume 113, Issue 20, Pages 4841-4852

Publisher

American Society of Hematology

Online

2008-12-25

DOI

10.1182/blood-2008-08-172726

References

View 1 related references

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BLOOD

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Ask a Question. Answer a Question.